• Explore /
  • Poster
  • / Methodology of the SORENTO clinical trial: Assessing the efficacy and safety of high exposure octreotide subcutaneous depot in patients with GEP-NETs.

Methodology of the SORENTO clinical trial: Assessing the efficacy and safety of high exposure octreotide subcutaneous depot in patients with GEP-NETs.

Abstract Poster

Authors

null

Simron Singh

Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Simron Singh , Jaume Capdevila , Jennifer A. Chan , Wouter de Herder , Diego Ferone , Daniel M. Halperin , Josh Mailman , Mozhgan Dorkhan , Lisa Hellström , Agneta Svedberg , Fredrik Tiberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Neuroendocrine/Carcinoid

Clinical Trial Registration Number

NCT05050942

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS4178)

DOI

10.1200/JCO.2022.40.16_suppl.TPS4178

Abstract #

TPS4178

Poster Bd #

154b

Abstract Disclosures

Similar Posters

First Author: Aman Chauhan

Poster

2019 Gastrointestinal Cancers Symposium

Temozolomide in grade III neuroendocrine neoplasms (G3 NENs): A multicenter retrospective review.

Temozolomide in grade III neuroendocrine neoplasms (G3 NENs): A multicenter retrospective review.

First Author: David Chan

First Author: Paul Oberstein

First Author: James Yao